Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Hepatitis

  Free Subscription


02.04.2018

1 AIDS
1 Am J Epidemiol
1 Arch Virol
1 Cancer
2 Dig Dis Sci
1 Eur J Gastroenterol Hepatol
2 Hepatology
1 J Immunol
2 J Med Virol
5 J Viral Hepat
2 Lancet Gastroenterol Hepatol
1 Lancet Infect Dis
1 N Engl J Med
1 Pediatr Infect Dis J
3 PLoS One
3 Transplant Proc
5 Vaccine
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. MERCHANTE N, Rodriguez-Arrondo F, Revollo B, Merino E, et al
    Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/HCV-coinfected patients.
    AIDS. 2018 Mar 28. doi: 10.1097/QAD.0000000000001809.
    PubMed     Text format     Abstract available


    Am J Epidemiol

  2. KMUSH BL, Zaman K, Yunus M, Saha P, et al
    A Ten Year Immunopersistence Study of Hepatitis E Antibodies in Rural Bangladesh.
    Am J Epidemiol. 2018 Mar 23. pii: 4952150. doi: 10.1093.
    PubMed     Text format     Abstract available


    Arch Virol

  3. ELHELW DS, Riad SE, Shawer H, El-Ekiaby N, et al
    Correction to: Ectopic delivery of miR-200c diminishes hepatitis C virus infectivity through transcriptional and translational repression of Occludin.
    Arch Virol. 2018 Mar 24. pii: 10.1007/s00705-018-3798.
    PubMed     Text format     Abstract available


    Cancer

  4. FANG DM, Stewart SL
    Social-cultural, traditional beliefs, and health system barriers of hepatitis B screening among Hmong Americans: A case study.
    Cancer. 2018;124 Suppl 7:1576-1582.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  5. EFE C, Taii HA, Ytting H, Aehling N, et al
    Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis.
    Dig Dis Sci. 2018 Mar 22. pii: 10.1007/s10620-018-5011.
    PubMed     Text format     Abstract available

  6. ALEXANIAN D, Birg A, Volpicelli N, Glass J, et al
    Latent Hepatitis Virus Reactivation Due to Drug Reaction: DRESSed to Kill?
    Dig Dis Sci. 2018 Mar 29. pii: 10.1007/s10620-018-5028.
    PubMed     Text format    


    Eur J Gastroenterol Hepatol

  7. HUANG R, Wang J, Xia J, Hao Y, et al
    Platelets-to-lymphocyte ratio as a predictor of liver fibrosis and insulin resistance in hepatitis C virus infection: more evidence is needed.
    Eur J Gastroenterol Hepatol. 2018;30:583.
    PubMed     Text format    


    Hepatology

  8. GUO JT, Block TM
    Do hepatitis B surface antigens have any role in viral carcinogenesis?
    Hepatology. 2018 Mar 24. doi: 10.1002/hep.29886.
    PubMed     Text format    

  9. FAILLACI F, Marzi L, Critelli R, Milosa F, et al
    Liver Angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after HCV direct-acting antivirals.
    Hepatology. 2018 Mar 31. doi: 10.1002/hep.29911.
    PubMed     Text format     Abstract available


    J Immunol

  10. HUANG S, Zou S, Chen M, Gao X, et al
    Local Stimulation of Liver Sinusoidal Endothelial Cells with a NOD1 Agonist Activates T Cells and Suppresses Hepatitis B Virus Replication in Mice.
    J Immunol. 2018 Mar 28. pii: jimmunol.1700921. doi: 10.4049/jimmunol.1700921.
    PubMed     Text format     Abstract available


    J Med Virol

  11. YANG N, Feng J, Zhou T, Li Z, et al
    Relationship between serum quantitative HBsAg and HBV DNA levels in chronic hepatitis B patients.
    J Med Virol. 2018 Mar 30. doi: 10.1002/jmv.25080.
    PubMed     Text format     Abstract available

  12. DENG H, Deng X, Liu Y, Xu Y, et al
    Naturally occurring antiviral drug resistance in HIV patients who are mono-infected or co-infected with HBV or HCV in China.
    J Med Virol. 2018 Mar 24. doi: 10.1002/jmv.25078.
    PubMed     Text format     Abstract available


    J Viral Hepat

  13. HOSHINO K, Sugiyama M, Date T, Maruwaka S, et al
    Phylogenetic and phylodynamic analysis of hepatitis C virus subtype 1a in Okinawa, Japan.
    J Viral Hepat. 2018 Mar 25. doi: 10.1111/jvh.12898.
    PubMed     Text format     Abstract available

  14. RICCO G, Popa DC, Cavallone D, Iacob S, et al
    Quantification of serum markers of hepatitis B (HBV) and Delta virus (HDV) infections in patients with chronic HDV infection.
    J Viral Hepat. 2018 Mar 25. doi: 10.1111/jvh.12895.
    PubMed     Text format     Abstract available

  15. WANG H, Swann R, Thomas E, Innes HA, et al
    Impact of previous hepatitis B infection on the clinical outcomes from chronic hepatitis C? A population-level analysis.
    J Viral Hepat. 2018 Mar 25. doi: 10.1111/jvh.12897.
    PubMed     Text format     Abstract available

  16. BOYD SD, Harrington P, Komatsu TE, Naeger LK, et al
    HCV Genotype 4, 5, and 6: Distribution of Viral Subtypes and Sustained Virologic Response Rates in Clinical Trials of Approved Direct-acting Antiviral Regimens.
    J Viral Hepat. 2018 Mar 25. doi: 10.1111/jvh.12896.
    PubMed     Text format     Abstract available

  17. GODOY P, Carmona G, Manzanares S, Jane M, et al
    Trends and risk factors of hepatitis A in Catalonia after the introduction of a hepatitis A+B vaccination program.
    J Viral Hepat. 2018 Mar 31. doi: 10.1111/jvh.12900.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  18. DUSHEIKO G, Agarwal K
    Delineating the global challenges of hepatitis B virus infection.
    Lancet Gastroenterol Hepatol. 2018 Mar 26. pii: S2468-1253(18)30093.
    PubMed     Text format    


  19. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study.
    Lancet Gastroenterol Hepatol. 2018 Mar 26. pii: S2468-1253(18)30056.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  20. WHITE PJ, Abubakar I
    Hepatitis C virus treatment as prevention in people who inject drugs.
    Lancet Infect Dis. 2018;18:379.
    PubMed     Text format    


    N Engl J Med

  21. LIANG TJ, Ward JW
    Hepatitis C in Injection-Drug Users - A Hidden Danger of the Opioid Epidemic.
    N Engl J Med. 2018;378:1169-1171.
    PubMed     Text format    


    Pediatr Infect Dis J

  22. CHOTUN N, Strobele S, Maponga TG, Andersson MI, et al
    Successful Treatment of a South African Pediatric Case of Acute Liver Failure Caused By Perinatal Transmission of Hepatitis B.
    Pediatr Infect Dis J. 2018 Mar 27. doi: 10.1097/INF.0000000000002054.
    PubMed     Text format     Abstract available


    PLoS One


  23. Retraction: rs10499194 polymorphism in the tumor necrosis factor-alpha inducible protein 3 (TNFAIP3) gene is associated with type-1 autoimmune hepatitis risk in Chinese Han population.
    PLoS One. 2018;13:e0195181.
    PubMed     Text format    

  24. DES JARLAIS DC, Cooper HLF, Arasteh K, Feelemyer J, et al
    Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for the current opioid epidemic in the US.
    PLoS One. 2018;13:e0194799.
    PubMed     Text format     Abstract available

  25. TI L, Socias ME, Wood E, Milloy MJ, et al
    The impact of methadone maintenance therapy on access to regular physician care regarding hepatitis C among people who inject drugs.
    PLoS One. 2018;13:e0194162.
    PubMed     Text format     Abstract available


    Transplant Proc

  26. TENORIO GONZALEZ E, Robles Diaz M, Sanjuan Jimenez R, Gonzalez Grande R, et al
    Retransplant Due to Fulminant Hepatic Failure From Hepatitis E Virus: A Case Report.
    Transplant Proc. 2018;50:685-686.
    PubMed     Text format     Abstract available

  27. NOGUERAS LOPEZ F, Lopez Garrido A, Ortega Suazo EJ, Vadillo Calles F, et al
    Therapy With Direct-Acting Antiviral Agents for Hepatitis C in Liver Transplant Recipients.
    Transplant Proc. 2018;50:631-633.
    PubMed     Text format     Abstract available

  28. CAICEDO LA, Delgado A, Garcia VH, Aristizabal AM, et al
    Liver Transplantation in Hepatitis C-Infected Patients: Experience From a South American Transplant Center.
    Transplant Proc. 2018;50:493-498.
    PubMed     Text format     Abstract available


    Vaccine

  29. LU PJ, O'Halloran AC, Williams WW, Nelson NP, et al
    Hepatitis B vaccination coverage among adults aged>/=18years traveling to a country of high or intermediate endemicity, United States, 2015.
    Vaccine. 2018 Mar 28. pii: S0264-410X(18)30375.
    PubMed     Text format     Abstract available

  30. LI X, Xu Y, Dong Y, Yang X, et al
    Monitoring the efficacy of infant hepatitis B vaccination and revaccination in 0- to 8-year-old children: Protective anti-HBs levels and cellular immune responses.
    Vaccine. 2018 Mar 24. pii: S0264-410X(18)30389.
    PubMed     Text format     Abstract available

  31. WEI S, Lei Y, Yang J, Wang X, et al
    Neutralization effects of antibody elicited by chimeric HBV S antigen viral-like particles presenting HCV neutralization epitopes.
    Vaccine. 2018 Mar 22. pii: S0264-410X(18)30381.
    PubMed     Text format     Abstract available

  32. KLINGER G, Chodick G, Levy I
    Long-term immunity to hepatitis B following vaccination in infancy: Real-world data analysis.
    Vaccine. 2018 Mar 21. pii: S0264-410X(18)30373.
    PubMed     Text format     Abstract available

  33. LIU Y, Ma C, Jia H, Xu E, et al
    Knowledge, attitudes, and practices regarding hepatitis B vaccination among hospital-based doctors and nurses in China: Results of a multi-site survey.
    Vaccine. 2018 Mar 19. pii: S0264-410X(18)30354.
    PubMed     Text format     Abstract available


    Virology

  34. BI X, Tong S
    Impact of immune escape mutations and N-linked glycosylation on the secretion of hepatitis B virus virions and subviral particles: Role of the small envelope protein.
    Virology. 2018;518:358-368.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: